Testing effectiveness (Phase 2)Looking for participantsNCT05939037
What this trial is testing
Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related Polyneuropathy
Who this might be right for
Monoclonal Gammopathy of Uncertain Significance
UMC Utrecht 35